Last $14.94 USD
Change Today +0.44 / 3.03%
Volume 125.7K
OSIR On Other Exchanges
Symbol
Exchange
NASDAQ GM
Berlin
As of 8:10 PM 07/29/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Peter Friedli

Co-Founder and Chairman, Osiris Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 25 board members in 9 different organizations across 9 different industries.

See Board Relationships
60$149,300

Background*

Mr. Peter Friedli serves as the Chairman and Investment Manager at New Venturetec. Mr. Friedli serves as the Head of Friedli Corporate Finance Inc. and has been its Principal since inception in 1986. He co-founded Osiris Therapeutics, Inc. in 1992. He is also the Founder of Friedli Corporate Finance. He serves as the President at InVenture, Inc. He served as an Investment Manager of InVenture Ltd. Prior to joining Friedli Corporate Finance, he worked as an International ...

Read Full Background

Corporate Headquarters*

7015 Albert Einstein Drive
Columbia, Maryland 21046

United States

Phone: 443-545-1800
Fax: 443-545-1701

Board Members Memberships*

Chairman of the Board
Chairman
Co-Founder and Director
Chairman, Investment Manager and President of the Board of Directors of Venturetec Inc
Director
Chairman
Chairman
Principal and Co-Founder
1998-Present
Director
1999-2005
Former Director and Member of Compensation Committee
2000-2007
Former Director and Member of Compensation Committee
2004-Present
Co-Founder and Chairman

Education*

Unknown/Other Education 1985
Universität Basel

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Calculated Compensation$149,300
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OSIR:US $14.94 USD +0.44

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John A. Scarlett M.D.Chief Executive Officer, President and Director
Geron Corporation
$569.3K
Robin L. Smith M.D., MBA,RoExecutive Chairman and Chief Executive Officer
Neostem, Inc.
$945.0K
Thomas Axelsson M.Sc.Chief Executive Officer
Vitrolife AB (publ)
kr3.7M
Paul K. Wotton Ph.D.Chief Executive Officer and President
Advanced Cell Technology Inc.
--
Keith Murphy Chairman, Chief Executive Officer, President, Member of Audit Committee and Member of Science & Technology Committee
Organovo Holdings, Inc.
$362.9K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OSIRIS THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.